title: Endocrine treatment and prevention of breast and gynaecological cancers.
authors.forename: P
authors.initials: P
authors.lastname: Neven
authors.forename: I
authors.initials: I
authors.lastname: Vergote
authors.forename: J
authors.initials: J
authors.lastname: Van Ginderachter
authors.forename: P
authors.initials: P
authors.lastname: van Dam
authors.forename: W
authors.initials: W
authors.lastname: Tjalma
authors.forename: C
authors.initials: C
authors.lastname: De Rop
authors.forename: F
authors.initials: F
authors.lastname: De Prins
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000517:prevention & control; D017024:Chemotherapy, Adjuvant; D004965:Estrogen Antagonists / Q000627:therapeutic use; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D009362:Neoplasm Metastasis; D017698:Postmenopause; D011960:Receptors, Estrogen / Q000502:physiology
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D020847:Estrogen Receptor Modulators; D011960:Receptors, Estrogen